Objective:This paper aims to investigate the value of individualized care for critically ill patients receiving continuous blood purification therapy.Methods:89 cases of critically ill patients who were treated from J...Objective:This paper aims to investigate the value of individualized care for critically ill patients receiving continuous blood purification therapy.Methods:89 cases of critically ill patients who were treated from June 2021 to June 2023 were randomly divided into groups,with individualized care in group A and routine care in group B.The differences in clinical indicators,purification effect,quality of life,and complications of blood purification were compared between the groups.Results:Heart rate,respiration,body temperature,and other indicators in group A were better than those in group B,P<0.05.C-reactive protein(CRP),β2-microglobulin(β2-MG),blood urea nitrogen(BUN),and phosphorus(P)in group A were lower than those in group B,P<0.05.Group A had higher quality of life than Group B,P<0.05.The complication rate of blood purification in Group A was lower than that in Group B,P<0.05.Conclusion:During continuous blood purification in critically ill patients,individualized nursing intervention can enhance the effect of blood purification,improve the physiological indicators of patients,and reduce the complications of blood purification,which is highly effective and feasible.展开更多
AIM: To determine the frequencies of HGV and TTV infections in blood donors in Hangzhou. METHODS: RT-nested PCR for HGV RNA detection and semi-nested PCR for TTV DNA detection in the sera from 203 blood donors, and nu...AIM: To determine the frequencies of HGV and TTV infections in blood donors in Hangzhou. METHODS: RT-nested PCR for HGV RNA detection and semi-nested PCR for TTV DNA detection in the sera from 203 blood donors, and nucleotide sequence analysis were performed. RESULTS: Thirty-two (15.8%) and 30 (14.8%) of the 203 serum samples were positive for HGV RNA and TTV DNA, respectively. And 5 (2.5%) of the 203 serum samples were detectable for both HGV RNA and TTV DNA. Homology of the nucleotide sequences of HGV RT-nested PCR products and TTV semi-nested PCR products from 3 serum samples compared with the reported HGV and TTV sequences was 89.36%, 87.94%, 88.65% and 63.51%, 65.77% and 67.12%, respectively. CONCLUSION: The infection rates of HGV and/or TTV in blood donors are relatively high, and to establish HGV and TTV examinations to screen blood donors is needed for transfusion security. The genomic heterogeneity of TTV or HGV is present in the isolates from different areas.展开更多
目的系统评价无肝素抗凝与低分子肝素抗凝用于有出血倾向的危重患者连续性血液净化抗凝治疗的安全性和有效性。方法计算机检索PubMed、MEDLINE、RNAO、OVID、Web of Knowledge、Nursing Consult、EMbase、中国生物医学文献数据库、万方...目的系统评价无肝素抗凝与低分子肝素抗凝用于有出血倾向的危重患者连续性血液净化抗凝治疗的安全性和有效性。方法计算机检索PubMed、MEDLINE、RNAO、OVID、Web of Knowledge、Nursing Consult、EMbase、中国生物医学文献数据库、万方数据库和中国学术期刊全文数据库中关于无肝素抗凝与低分子肝素抗凝用于有出血倾向的危重患者连续性血液净化抗凝治疗效果的随机对照试验(RCT)和半随机对照试验(q-RCT),同时筛检纳入文献的参考文献。由两名研究者对文献质量进行严格评价和资料提取,对符合质量标准的RCT进行Meta分析。结果共纳入7篇文献,Meta分析的结果显示:无肝素抗凝能降低有出血倾向的危重患者出血的发生率。结论无肝素抗凝对于预防有出血倾向的危重患者连续性血液净化抗凝治疗出血并发症的发生具有显著效果。展开更多
文摘Objective:This paper aims to investigate the value of individualized care for critically ill patients receiving continuous blood purification therapy.Methods:89 cases of critically ill patients who were treated from June 2021 to June 2023 were randomly divided into groups,with individualized care in group A and routine care in group B.The differences in clinical indicators,purification effect,quality of life,and complications of blood purification were compared between the groups.Results:Heart rate,respiration,body temperature,and other indicators in group A were better than those in group B,P<0.05.C-reactive protein(CRP),β2-microglobulin(β2-MG),blood urea nitrogen(BUN),and phosphorus(P)in group A were lower than those in group B,P<0.05.Group A had higher quality of life than Group B,P<0.05.The complication rate of blood purification in Group A was lower than that in Group B,P<0.05.Conclusion:During continuous blood purification in critically ill patients,individualized nursing intervention can enhance the effect of blood purification,improve the physiological indicators of patients,and reduce the complications of blood purification,which is highly effective and feasible.
文摘AIM: To determine the frequencies of HGV and TTV infections in blood donors in Hangzhou. METHODS: RT-nested PCR for HGV RNA detection and semi-nested PCR for TTV DNA detection in the sera from 203 blood donors, and nucleotide sequence analysis were performed. RESULTS: Thirty-two (15.8%) and 30 (14.8%) of the 203 serum samples were positive for HGV RNA and TTV DNA, respectively. And 5 (2.5%) of the 203 serum samples were detectable for both HGV RNA and TTV DNA. Homology of the nucleotide sequences of HGV RT-nested PCR products and TTV semi-nested PCR products from 3 serum samples compared with the reported HGV and TTV sequences was 89.36%, 87.94%, 88.65% and 63.51%, 65.77% and 67.12%, respectively. CONCLUSION: The infection rates of HGV and/or TTV in blood donors are relatively high, and to establish HGV and TTV examinations to screen blood donors is needed for transfusion security. The genomic heterogeneity of TTV or HGV is present in the isolates from different areas.
文摘目的系统评价无肝素抗凝与低分子肝素抗凝用于有出血倾向的危重患者连续性血液净化抗凝治疗的安全性和有效性。方法计算机检索PubMed、MEDLINE、RNAO、OVID、Web of Knowledge、Nursing Consult、EMbase、中国生物医学文献数据库、万方数据库和中国学术期刊全文数据库中关于无肝素抗凝与低分子肝素抗凝用于有出血倾向的危重患者连续性血液净化抗凝治疗效果的随机对照试验(RCT)和半随机对照试验(q-RCT),同时筛检纳入文献的参考文献。由两名研究者对文献质量进行严格评价和资料提取,对符合质量标准的RCT进行Meta分析。结果共纳入7篇文献,Meta分析的结果显示:无肝素抗凝能降低有出血倾向的危重患者出血的发生率。结论无肝素抗凝对于预防有出血倾向的危重患者连续性血液净化抗凝治疗出血并发症的发生具有显著效果。
